Understanding Canine Bladder Cancer Stages

Author

Posted Oct 19, 2024

Reads 1.2K

A Veterinarian Vaccinating a Dog
Credit: pexels.com, A Veterinarian Vaccinating a Dog

Canine bladder cancer is a serious health issue that affects many dogs. It's essential to understand the different stages of this disease to provide the best possible care for your furry friend.

The American Veterinary Medical Association (AVMA) identifies four stages of canine bladder cancer: Stage I, Stage II, Stage III, and Stage IV. Each stage has distinct characteristics that determine the prognosis and treatment options.

As the cancer progresses, it can invade surrounding tissues and organs, leading to more severe symptoms. In Stage II, the cancer has grown beyond the bladder muscle and into the surrounding connective tissue.

Symptoms can vary depending on the stage, but common signs include frequent urination, blood in the urine, and abdominal pain.

A fresh viewpoint: Canine Bladder Cancer

Diagnosis and Evaluation

A diagnosis of canine bladder cancer requires a combination of tests, including urinalysis, urine sediment cytology, bladder tumor antigen testing on a urine sample, ultrasound of the urinary bladder and urethra, and biopsy of the affected area.

Credit: youtube.com, Canine Bladder Cancer Explained

To determine the extent of the tumor, a process called tumor staging is performed. This involves radiographs of the thorax to look for lung metastasis, radiographs and ultrasound of the abdomen to look for metastasis in the abdomen and to assess any changes in the kidneys that result from obstructed urine flow, and imaging of the bladder to determine the exact location and size of the tumor within the bladder.

Your veterinarian may suspect a urinary tract tumor if your pet experiences recurrent urinary tract infections or the infections do not resolve with treatment. In this case, abdominal radiographs or ultrasound are usually recommended to determine the cause, such as an abnormal mass in the kidneys, bladder, or elsewhere along the urinary tract.

A biopsy is a surgical excision of one or more pieces of the abnormal tissue or tumor. This biopsy is then examined by a veterinary pathologist under the microscope. This is called histopathology. It's not only helpful to make a diagnosis but can also indicate how the tumor is likely to behave.

Tissue samples of any bladder or urethral masses can be obtained by catheterization. This involves placing a urinary catheter into the urethra to retrieve potentially cancerous cells from the lining of the urethra or bladder. Another diagnostic option is cystoscopy, which involves passing a small scope (tube with camera) into the urethra and into the bladder to examine these areas, as well as obtain tissue biopsies for a pathologist to review.

Credit: youtube.com, Bladder Cancer in Dogs: Is It a Death Sentence? | Dr. Nancy Reese, DVM, PhD Deep Dive

Here are the diagnostic tests used to diagnose bladder cancer in dogs:

  • Urinalysis
  • Urine sediment cytology
  • Bladder tumor antigen testing on a urine sample
  • Ultrasound of the urinary bladder and urethra
  • Biopsy of the affected area (sometimes)

It's worth noting that there is a urine test for a specific mutation in the BRAF gene in the bladder cancer cells. This test may be recommended by your veterinarian or veterinary oncologist.

For more insights, see: Canine Distemper Test

Signs of

Signs of canine bladder cancer can be subtle, but knowing what to look for can help you catch the disease early. Blood in the urine is a common sign, as well as straining to urinate and making repeated frequent attempts to urinate.

Dogs may also have urinary accidents in the house, which can be a sign of bladder cancer. However, it's essential to remember that these symptoms can also be caused by urinary tract infections, so it's crucial to seek veterinary care to determine the cause.

In addition to these symptoms, dogs with bladder cancer may also experience difficulty urinating or have accidents in the house. Discolored or bloody urine can also be a sign, and persistent urinary tract infections that are resistant to treatment can be a red flag.

Credit: youtube.com, Symptoms of Bladder Cancer in Pets, How to Catch this Early: Vlog 109

As the disease progresses, dogs may experience lameness due to the cancer spreading to the dog's bones or lungs. In the later stages of bladder cancer, some dogs may have a paraneoplastic syndrome called hypertrophic osteopathy, which can cause lameness.

Here are some common signs of bladder cancer in dogs:

  • Inability to urinate
  • Difficult urination
  • Blood in the urine
  • Urinary incontinence

Remember, if your dog is displaying any of these symptoms, it's essential to seek veterinary care as soon as possible. The symptoms of bladder cancer can be caused by a number of serious conditions that require treatment.

Treatment and Care

Treatment options for canine bladder cancer depend on the stage and grade of the tumor, as well as the dog's overall health.

Surgery is often the primary treatment for canine bladder cancer, and it can be performed to remove the tumor, the bladder, or other affected organs.

Chemotherapy and radiation therapy may be used in combination with surgery to kill any remaining cancer cells.

Here's an interesting read: Canine Cancer Treatment

Credit: youtube.com, Dog Bladder Cancer Treatment Options: Vlog 111

Prognosis and quality of life for dogs with bladder cancer can be improved with proper treatment and care, but it's essential to work closely with a veterinarian to determine the best course of action.

With proper care and management, some dogs with bladder cancer can live for several months to a year or more after diagnosis.

Radiation Therapy

Radiation therapy is a treatment option for bladder cancer in dogs. It has been used to successfully control the growth of transitional cell carcinoma (TCC) in the bladder.

Radiation given in traditional doses can lead to complications such as a scarred, shrunken bladder and irritation to surrounding organs. The bladder's movement and changing shape make it a challenging area to target with radiation.

With better imaging, radiation therapy of the bladder has become much safer than in years past. The optimal treatment protocols and the level of benefit offered by radiation therapy require further study.

TCC Symptomatic Care

Credit: youtube.com, TCC treatment

As your dog's condition progresses, it's essential to understand the changing symptoms of TCC. Inability to urinate is a common symptom that can be challenging to manage.

If your dog is experiencing difficulty urinating, it's crucial to seek veterinary care immediately. This symptom can be a sign of a more serious issue.

Blood in the urine is another common symptom of TCC. This can be a distressing sign for both you and your dog.

Urinary incontinence is also a symptom of TCC. This can lead to accidents in the house, which can be frustrating and messy.

Here are some common symptoms of TCC as the disease progresses:

  • Inability to urinate
  • Difficult urination
  • Blood in the urine
  • Urinary incontinence

Monitoring and Prognosis

Monitoring changes in tumor size is crucial in canine bladder cancer, as symptoms don't always follow changes in tumor size. Measuring the tumor before and after treatment is essential to determine if the treatment is working.

If the tumor is shrinking or remaining stable in size after 4-8 weeks of treatment, and the dog is feeling well, the same treatment is continued. However, if the cancer is not responding, a different treatment is initiated.

The prognosis for dogs with bladder cancer varies greatly depending on the extent of the disease, its location, and the treatment chosen. With surgical intervention, an attempt is made to remove as much of the tumor as possible to increase survival time.

Monitoring Plan

Credit: youtube.com, Prognosis Monitoring System(PMS) Introduction

At Purdue University, the typical plan for monitoring dogs with Transitional Cell Carcinoma (TCC) involves measuring the tumor before treatment, and then remeasuring it after 4-8 weeks of treatment.

This is crucial because a dog's clinical signs, or symptoms, don't always follow changes in tumor size. If a dog develops a urinary tract infection, their symptoms will be much worse, yet the tumor might not be growing.

The size of the tumor is an important indicator of how well the treatment is working. If the tumor is shrinking or remaining stable in size after 4-8 weeks, and the dog is feeling well on that therapy, then the same treatment is continued.

However, if the cancer is not responding, or if the dog doesn't feel well on that particular treatment, then a different treatment is initiated. After each 4-8 weeks of treatment, the tumor is remeasured to confirm the treatment is still beneficial and to alter therapy as indicated.

TCC Prognosis

Credit: youtube.com, Transitional Cell Carcinoma in Dogs (TCC)

The prognosis for dogs with TCC varies greatly depending on several factors, including the growth rate of the tumor, its location, and whether it has spread to other organs.

Survival rates can range from a few days to over two years, with some dogs living longer with more aggressive treatment protocols.

Early studies showed a dismal prognosis, with some dogs living only 109 days after diagnosis. However, with advancements in treatment, median survival times have improved to 244 days with piroxicam treatment and 299 days with vinblastine and piroxicam.

Factors that negatively affect survival time include extensive tumor growth within the bladder, spread of the tumor beyond the bladder, and involvement of the tumor in the prostate gland.

Approximately 20% of dogs with TCC have detectable metastasis at diagnosis, and 50-60% have metastasis at death.

Despite progress in treating TCC, there is still much to be learned, and ongoing clinical trials aim to improve treatment efficacy and patient outcomes.

With appropriate treatment, many dogs with bladder cancer can survive for 6-12 months after diagnosis, and some may even live longer with more aggressive treatment protocols.

For your interest: Canine Cancer Prognosis

Frequently Asked Questions

What are the final stages of bladder cancer in dogs?

Final stages of bladder cancer in dogs can be fatal if left untreated, and may also cause breathing difficulties, nausea, vomiting, and loss of appetite due to tumor spread to the lungs and liver

How aggressive is bladder cancer in dogs?

Bladder cancer in dogs is an aggressive form of cancer that can quickly spread to other parts of the body. Its aggressive nature makes prompt treatment crucial for managing the disease.

Sources

  1. Urinary Tract Tumors (vcahospitals.com)
  2. Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors (nih.gov)
  3. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder (nih.gov)
  4. Naturally-occurring canine transitional cell carcinoma of the urinary bladder, a relevant model of human invasive bladder cancer (nih.gov)
  5. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer (nih.gov)
  6. Effects of the cyclooxygenase inhibitor, piroxicam in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer (nih.gov)
  7. Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terrier dogs (nih.gov)
  8. Topical spot-on flea and tick products and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terrier dogs (nih.gov)
  9. Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers (nih.gov)
  10. Carboplatin and piroxicam in 31 dogs with transitional cell carcinoma of the urinary bladder (nih.gov)
  11. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder (nih.gov)
  12. Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma (nih.gov)
  13. Lipid profiles of canine invasive transitional cell carcinoma of the urinary bladder and adjacent normal tissue by desorption electrospray ionization imaging mass spectrometry (nih.gov)
  14. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement animal model of invasive urinary bladder cancer (nih.gov)
  15. Phase  I clinical trial and pharmacokinetics of intravesical Mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder (nih.gov)
  16. clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder (nih.gov)
  17. Comparison of cystoscopy vs surgery in obtaining diagnostic biopsy specimens from dogs with transitional cell carcinoma of the urinary bladder and urethra (semanticscholar.org)
  18. Accuracy of three-dimensional and two-dimensional ultrasonography in measuring tumor volume in dogs with transitional cell carcinoma of the urinary bladder (nih.gov)
  19. Outcome of urethral stenting for management of obstruction secondary to transitional cell carcinoma in 19 dogs (2007-2010) (nih.gov)
  20. Subcutaneous 5-azacitidine treatment of naturally-occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development (nih.gov)
  21. NMR-based metabolomics study of canine bladder cancer (nih.gov)
  22. Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985-2010) (nih.gov)
  23. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder (nih.gov)
  24. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma (nih.gov)
  25. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development (nih.gov)
  26. Management of transitional cell carcinoma of the urinary bladder in dogs: a review (nih.gov)
  27. Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test (nih.gov)
  28. Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer (nih.gov)
  29. A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma (nih.gov)
  30. Skeletal Metastasis of Canine Urothelial Carcinoma: Pathologic and Computed Tomographic Features (nih.gov)
  31. Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs (nih.gov)
  32. Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs (nih.gov)
  33. Evaluation of two-dimensional ultrasonography and computed tomography in the mapping and measuring of canine urinary bladder tumors (nih.gov)
  34. Naturally-occurring canine invasive urothelial carcinoma: A model for emerging therapies (nih.gov)
  35. Fatty acid patterns detected by ambient ionization mass spectrometry in canine invasive urothelial carcinoma from dogs of different breeds (nih.gov)
  36. Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma (nih.gov)
  37. Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer (nih.gov)
  38. Immune checkpoint B7x (B7-H4/B7S1/VTCN1) is over expressed in spontaneous canine bladder cancer: The first report and its implications in a preclinical model. Bladder Cancer (nih.gov)
  39. RNAseq expression patterns of canine invasive urothelial carcinoma reveal two distinct tumor clusters and shared regions of dysregulation with human bladder tumors (nih.gov)
  40. Naturally-occurring invasive urothelial carcinoma in dogs, a unique model to drive advances in managing muscle invasive bladder cancer in humans (nih.gov)
  41. Assessment of urinary 15-F2 -isoprostanes in dogs with urothelial carcinoma of the urinary bladder and other lower urinary tract diseases (nih.gov)
  42. Phase I / II trial of vemurafenib in dogs with naturally-occurring, BRAF-mutated urothelial carcinoma (nih.gov)
  43. The miRNome of canine invasive urothelial carcinoma. (nih.gov)
  44. Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma (nih.gov)
  45. cTULIP: application of a human-based RNA-seq primary tumor classification tool for cross-species primary tumor classification in canine (nih.gov)
  46. Association between cigarette smoke exposure and urinary bladder cancer in Scottish terriers in a cohort study (nih.gov)
  47. Dog Bladder Cancer: Causes, Symptoms & Treatments (northeast-vet.com)
  48. Bladder Cancer in Dogs: Symptoms, Treatment and Life ... (petmd.com)
  49. Bladder Cancer in Dogs | Huntersville Vet Specialists (carolinavet.com)

Shawna Welch

Writer

Shawna Welch is a versatile and engaging writer with a passion for exploring complex topics in an approachable way. With a keen interest in animal behavior, Shawna has developed a niche expertise in canine behavioral issues, shedding light on common problems and offering actionable advice for pet owners. Her writing style is characterized by clarity, empathy, and a commitment to accuracy, making her a trusted voice in the field.